Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Medtronic
Federal Trade Commission
McKinsey
Chubb
UBS
Harvard Business School
McKesson
Cerilliant
Farmers Insurance

Generated: February 25, 2018

DrugPatentWatch Database Preview

ADRENALIN Drug Profile

« Back to Dashboard

Which patents cover Adrenalin, and when can generic versions of Adrenalin launch?

Adrenalin is a drug marketed by Par Sterile Products and is included in two NDAs. There are two patents protecting this drug and one Paragraph IV challenge.

This drug has three patent family members in three countries.

The generic ingredient in ADRENALIN is epinephrine. There are nineteen drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the epinephrine profile page.

US Patents and Regulatory Information for ADRENALIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Sterile Products ADRENALIN epinephrine SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS 204200-001 Dec 7, 2012 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Par Sterile Products ADRENALIN epinephrine SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS 204640-001 Dec 18, 2013 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Par Sterile Products ADRENALIN epinephrine SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS 204200-001 Dec 7, 2012 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Par Sterile Products ADRENALIN epinephrine SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS 204640-001 Dec 18, 2013 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for ADRENALIN
Drugname Dosage Strength RLD Submissiondate
➤ Subscribe Injection 1 mg/mL ampules ➤ Subscribe 3/9/2016

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Merck
AstraZeneca
Deloitte
Chubb
Baxter
Chinese Patent Office
Cipla
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot